These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39022058)

  • 1. Genetic landscape for majority and minority HIV-1 drug resistance mutations in antiretroviral therapy naive patients in Accra, Ghana.
    Appiah P; Gbassana G; Adusei-Poku M; Obeng BM; Duedu KO; Sagoe KWC
    Heliyon; 2024 Jun; 10(12):e33180. PubMed ID: 39022058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
    Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
    Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance.
    Novitsky V; Nyandiko W; Vreeman R; DeLong AK; Manne A; Scanlon M; Ngeresa A; Aluoch J; Sang F; Ashimosi C; Jepkemboi E; Orido M; Hogan JW; Kantor R;
    Microbiol Spectr; 2022 Dec; 10(6):e0345422. PubMed ID: 36445146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of an
    Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
    May S; Adamska E; Tang J
    J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
    Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
    BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy.
    Deletsu SD; Maina EK; Quaye O; Ampofo WK; Awandare GA; Bonney EY
    Medicine (Baltimore); 2020 Feb; 99(7):e18777. PubMed ID: 32049783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.
    Moscona R; Ram D; Wax M; Bucris E; Levy I; Mendelson E; Mor O
    J Int AIDS Soc; 2017 Aug; 20(1):21846. PubMed ID: 28799325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
    Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
    J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.
    Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China.
    Li M; Liang S; Zhou C; Chen M; Liang S; Liu C; Zuo Z; Liu L; Feng Y; Song C; Xing H; Ruan Y; Shao Y; Liao L
    Pathogens; 2021 Feb; 10(3):. PubMed ID: 33668946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
    Baxter JD; Dunn D; Tostevin A; Marvig RL; Bennedbaek M; Cozzi-Lepri A; Sharma S; Kozal MJ; Gompels M; Pinto AN; Lundgren J;
    HIV Med; 2021 May; 22(5):360-371. PubMed ID: 33369017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HIV-1 Integrase Strand Transfer Inhibitor Resistance in Treatment-Naïve Voluntary Counselling and Testing Clients by Population Sequencing and Illumina Next-Generation Sequencing in Taiwan.
    Tsai HC; Chen IT; Tsai KW; Lee SS; Chen YS
    Infect Drug Resist; 2020; 13():4519-4529. PubMed ID: 33364799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.
    Silver N; Paynter M; McAllister G; Atchley M; Sayir C; Short J; Winner D; Alouani DJ; Sharkey FH; Bergefall K; Templeton K; Carrington D; Quiñones-Mateu ME
    AIDS Res Ther; 2018 Nov; 15(1):18. PubMed ID: 30409215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China.
    Li Q; Yu F; Song C; Zhao H; Xiao Q; Lao X; Yang S; Tang Y; Zhang F
    Infect Drug Resist; 2022; 15():6711-6722. PubMed ID: 36438645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya.
    Hassan AS; Bibby DF; Mwaringa SM; Agutu CA; Ndirangu KK; Sanders EJ; Cane PA; Mbisa JL; Berkley JA
    PLoS One; 2019; 14(2):e0210559. PubMed ID: 30759103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa.
    Ogola B; Matume ND; Mavhandu-Ramarumo LG; Tebit DM; Bessong PO
    AIDS Res Hum Retroviruses; 2022 Mar; 38(3):248-256. PubMed ID: 34107774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Transmitted Drug Resistance among HIV-1 Patients in the Aegean Region: Results from the Western Part of Turkey.
    Sertoz R; Tekin D; Erensoy S; Biceroglu S; Kaptan F; Köse S; Ozkan H; Cetin B; Türken M; Gokengin D
    Curr HIV Res; 2023; 21(2):109-116. PubMed ID: 37231747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.